253 related articles for article (PubMed ID: 2560794)
61. Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte.
Santoli D; Trinchieri G; Lief FS
J Immunol; 1978 Aug; 121(2):526-31. PubMed ID: 681748
[TBL] [Abstract][Full Text] [Related]
62. Herpes simplex virus-1-specific human cytotoxic T lymphocytes are induced in vitro by autologous virus-infected mononuclear cells.
Maccario R; Revello MG; Comoli P; Gerna G
Viral Immunol; 1992; 5(2):93-103. PubMed ID: 1319712
[TBL] [Abstract][Full Text] [Related]
63. In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.
Wilhelm SA; Mukherji B
J Clin Invest; 1985 Apr; 75(4):1162-8. PubMed ID: 3988936
[TBL] [Abstract][Full Text] [Related]
64. Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody.
Ching C; Lopez C
Infect Immun; 1979 Oct; 26(1):49-56. PubMed ID: 227799
[TBL] [Abstract][Full Text] [Related]
65. Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay.
Martin-Kleiner I; Gabrilovac J
Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):37-57. PubMed ID: 8683038
[TBL] [Abstract][Full Text] [Related]
66. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells.
Santoli D; Trinchieri G; Koprowski H
J Immunol; 1978 Aug; 121(2):532-8. PubMed ID: 150448
[TBL] [Abstract][Full Text] [Related]
67. Human antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected autologous and allogeneic cells.
Kohl S; Moore CM
Immunology; 1983 Jan; 48(1):187-93. PubMed ID: 6848451
[TBL] [Abstract][Full Text] [Related]
68. Reduced antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells of salivary polymorphonuclear leukocytes and inhibition of peripheral blood polymorphonuclear leukocyte cytotoxicity by saliva.
Ashkenazi M; Kohl S
J Immunol; 1990 Jun; 144(12):4781-7. PubMed ID: 1972168
[TBL] [Abstract][Full Text] [Related]
69. Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus.
Shore SL; Black CM; Melewicz FM; Wood PA; Nahmias AJ
J Immunol; 1976 Jan; 116(1):194-201. PubMed ID: 173757
[TBL] [Abstract][Full Text] [Related]
70. Cytotoxic activity of intestinal lamina propria lymphocytes on human immunodeficiency virus (HIV)-infected cells.
Di Massimo AM; Placido R; Bach S; Anastasi AM; Mastino A; Capobianchi MR; Colizzi V
Immunology; 1992 May; 76(1):117-21. PubMed ID: 1628889
[TBL] [Abstract][Full Text] [Related]
71. Individual NK cell clones lyse both tumor cell targets and herpes simplex virus-infected fibroblasts in the absence of interferon.
Canessa A; Chatterjee S; Whitley RJ; Prasthofer EF; Grossi CE; Tilden AB
Viral Immunol; 1990; 3(3):217-24. PubMed ID: 1701642
[TBL] [Abstract][Full Text] [Related]
72. Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.
Mukherji B; Wilhelm SA; Guha A; Ergin MT
J Immunol; 1986 Mar; 136(5):1888-92. PubMed ID: 2419418
[TBL] [Abstract][Full Text] [Related]
73. In vitro effects of interleukin-2 and gamma globulin on immune dysfunction in a patient with severe mucocutaneous herpes simplex virus infection.
Wise SL; Yarbrough JA; Stafford CT; Leffell MS; Thompson WO; Ades EW
Ann Allergy; 1992 Jan; 68(1):47-52. PubMed ID: 1371040
[TBL] [Abstract][Full Text] [Related]
74. Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity.
Posavad CM; Rosenthal KL
J Virol; 1992 Nov; 66(11):6264-72. PubMed ID: 1328666
[TBL] [Abstract][Full Text] [Related]
75. Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines.
Leibson PJ; Hunter-Laszlo M; Douvas GS; Hayward AR
J Clin Immunol; 1986 May; 6(3):216-24. PubMed ID: 3013922
[TBL] [Abstract][Full Text] [Related]
76. Specifically immune mouse T-cells can destroy H-2 compatible murine target cells infected with herpes simplex virus types 1 or 2.
Sethi KK; Brandis H
Z Immunitatsforsch Immunobiol; 1977 Jul; 153(2):162-73. PubMed ID: 198986
[TBL] [Abstract][Full Text] [Related]
77. [Establishment of cytotoxic lymphocytes against autologous cholangiocarcinoma from the patient's blood lymphocytes cultured in T cell growth factor (TCGF)].
Yoshizumi Y
Nihon Geka Gakkai Zasshi; 1984 Jun; 85(6):563-72. PubMed ID: 6092889
[TBL] [Abstract][Full Text] [Related]
78. Mechanism of recognition of herpes simplex virus type 1-infected cells by natural killer cells.
López-Guerrero JA; Alarcón B; Fresno M
J Gen Virol; 1988 Nov; 69 ( Pt 11)():2859-68. PubMed ID: 2846762
[TBL] [Abstract][Full Text] [Related]
79. Natural killer-mediated lysis of some but not all HSV-1- or VSV-infected targets requires the participation of HLA-DR-positive accessory cells.
Howell DM; Fitzgerald-Bocarsly P
Immunology; 1991 Mar; 72(3):443-7. PubMed ID: 1851136
[TBL] [Abstract][Full Text] [Related]
80. In vitro sensitization of human lymphocytes against histiocytic lymphoma cell lines. II. Characterization of two different effector activities and of suppressor cells.
Treves AJ; Heidelberger E; Feldman M; Kaplan HS
J Immunol; 1978 Jul; 121(1):86-90. PubMed ID: 670709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
